Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss, prostate size, and urinary issues are related due to androgen effects.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Women with high androgen levels may have more severe COVID-19 symptoms.

Minoxidil can reduce functions related to androgen receptors.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Sex and stress steroids quickly change brain cell structures in the hippocampus.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Androgens can both increase and decrease hair growth in different parts of the body.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Some common medications can harm male fertility, but many effects can be reversed.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.